Here is a detailed overview of Daclatasvir Tablet 60 mg with icons:
💊 Daclatasvir Tablet 60 mg
🧪 Nature / Drug Class
🔹 Direct-Acting Antiviral (DAA)
🔹 NS5A Inhibitor
🔹 Targets Hepatitis C Virus (HCV) replication
🩺 Purpose / Indications
✅ Used in combination with other antivirals (e.g., Sofosbuvir) for treatment of:
- 🦠 Chronic Hepatitis C infection (all genotypes, esp. Genotype 3)
- 🩸 Patients with or without cirrhosis
- 👴 Adults and some adolescents (under physician guidance)
⚙️ Advantages
✔️ Highly effective cure rates (SVR > 90%) when combined with Sofosbuvir
✔️ Short treatment duration (usually 12–24 weeks)
✔️ Well tolerated, oral once-daily therapy
✔️ Useful in HIV/HCV co-infection cases
📦 Common Packaging
📦 Tablet: 60 mg
💊 Usually in blister packs of 28 tablets (4-week supply)
⚠️ Patient Advice / Precautions
🕐 Take once daily, at the same time each day
🍽️ Can be taken with or without food
➕ Must be used in combination (typically with Sofosbuvir) – never as monotherapy
🧪 Monitor liver function, HCV RNA, and hemoglobin if combined with ribavirin
⚠️ Dose adjustment may be required with certain antivirals (especially in HIV co-treatment)
🚫 Avoid in pregnancy if used with ribavirin
🧊 Storage
🌡️ Store at room temperature
🚫 Keep away from heat, moisture, and light
🧒 Keep out of reach of children